Option Care Health Boosts Share Buyback Program to $1 Billion, Provides Strong 2026 Guidance
OPCH sits 35% above its 52-week low of $23.68.
Summary
Option Care Health announced a significant expansion of its share repurchase program to $1 billion, alongside preliminary Q4 and full-year 2025 results and optimistic financial guidance for 2026.
Key Events · Financing and Capital Events · OPCH
-
Share Repurchase Program Expanded
The Board of Directors approved increasing the 2025 share repurchase authorization from $500 million to $1 billion, adding an additional $500 million in capacity. The total remaining capacity is now $693 million.
-
Preliminary 2025 Financial Results
The company reported preliminary full-year 2025 net revenue of $5.645 billion to $5.655 billion and Adjusted EBITDA of $469 million to $473 million.
-
Positive 2026 Financial Guidance
Option Care Health issued preliminary full-year 2026 guidance projecting net revenue of $5.8 billion to $6.0 billion and Adjusted EBITDA of $480 million to $505 million, indicating continued growth despite headwinds.
-
J.P. Morgan Healthcare Conference Presentation
The company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, with presentation materials furnished as an exhibit.
Analysis · OPCH · Industrial Applications And Services
The substantial increase in Option Care Health's share repurchase authorization to $1 billion, representing a significant portion of its market capitalization, is a strong positive signal of management's confidence in future performance and commitment to returning capital to shareholders. This capital allocation strategy, combined with preliminary 2025 results and optimistic 2026 guidance, suggests a robust financial outlook. While the 2026 guidance includes a headwind from Stelara biosimilars, the projected growth in revenue and Adjusted EBITDA indicates underlying business strength. Investors should view the expanded buyback as a material driver for shareholder value.
At the time of this filing, OPCH was trading at $32.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $23.68 to $35.53. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.